Why Is Exact Sciences (EXAS) Down 22.5% Since Last Earnings Report?Zacks Investment Research • 05/26/22
Exact Sciences: Sell-Off Provides An Opportunity To Buy At A Reasonable ValuationSeeking Alpha • 05/14/22
Updated ASCO Guidelines Strongly Recommend Use of the Oncotype DX Breast Recurrence Score® Test in Node-Negative and the Majority of Node-Positive Early-Stage Breast Cancer PatientsPRNewsWire • 04/28/22
Exact Sciences Corporation (EXAS) CEO Kevin Conroy on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 04/27/22
Exact Sciences (EXAS) Down 4.3% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 03/24/22
Tesla, Coinbase, Exact Sciences And More: How Cathie Wood's Top 10 Bets Are Faring In 2022 So FarBenzinga • 03/14/22
Exact Sciences (EXAS) Gains But Lags Market: What You Should KnowZacks Investment Research • 03/10/22
Katie Couric and Cologuard Team Up to Spread Awareness and Urgency for People to Get Screened for Colon CancerPRNewsWire • 03/07/22
Exact Sciences Corporation (EXAS) CEO Kevin Conroy on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/23/22
Earnings Preview: Exact Sciences (EXAS) Q4 Earnings Expected to DeclineZacks Investment Research • 02/08/22